1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Castleman Disease Treatment Market is undergoing dynamic change, driven by advances in clinical research, growing collaboration among biopharma innovators, and evolving patient management strategies. Senior decision-makers are confronting new opportunities and challenges as novel therapies and operational models redefine standards of care for this complex condition.
Market Snapshot: Castleman Disease Treatment Market
The Castleman Disease Treatment Market grew from USD 334.15 million in 2024 to USD 380.66 million in 2025. It is expected to continue growing at a CAGR of 13.67%, reaching USD 720.87 million by 2030. This rapid expansion highlights increased medical need, deeper clinical insight, and greater investment in targeted immunotherapies, combination regimens, and digital health solutions across global regions.
Scope & Segmentation
- Treatment Types: Chemotherapy (including combination and monotherapy), corticosteroids (dexamethasone, prednisone), siltuximab, and tocilizumab
- Line of Therapy: First line (combination therapy, monotherapy), second line, and later lines
- Distribution Channels: Offline, online
- End User Settings: Home care (self-administration, visiting nurse services), hospitals, specialty clinics
- Regions Covered: Americas (notably U.S. states such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; also Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major and emerging countries), Asia-Pacific (notably China, India, Japan, Australia, South Korea, and more)
- Key Companies Assessed: Janssen Biotech, Hoffmann-La Roche, Pfizer, EUSA Pharma, Swedish Orphan Biovitrum, Grifols, AbbVie, Takeda, Novartis, Bristol-Myers Squibb
Key Takeaways for Senior Decision-Makers
- Targeted immunotherapies are shaping therapeutic protocols by enabling precision interventions, often informed by biomarker-driven insights.
- Combination strategies—integrating chemotherapy with novel immunomodulators—are gaining favour in first-line regimens and demonstrate potential for improved patient outcomes in difficult-to-treat subgroups.
- Biologic agents, including monoclonal antibodies, continue to expand options for individuals not eligible for or refractory to standard treatments.
- Adoption of digital health tools, such as telemedicine and remote monitoring, is transforming patient engagement, supporting home-based care, and optimizing adverse event management.
- Shifts in distribution—especially telepharmacy—are supporting patient-centric delivery models while helping providers navigate geographic and logistical hurdles.
- Regional regulatory diversity and infrastructure investments are influencing adoption speed and access equity, highlighting the need for adaptable market entry strategies globally.
Tariff Impact on Castleman Disease Treatment Supply Chains
The implementation of new U.S. tariffs in 2025 is increasing procurement costs for key biologic inputs and laboratory consumables. Supply chain managers and manufacturers are reassessing sourcing strategies, pursuing alternative vendors, and strengthening domestic capabilities to buffer against tariff-driven volatility. These measures aim to maintain continuity of care and minimize disruptions to therapy access.
Methodology & Data Sources
This report uses a hybrid approach combining interviews with clinicians, regulatory specialists, and patient advocates; a systematic literature review of clinical guidelines and peer-reviewed publications; and advanced data analytics, including thematic analysis and statistical aggregation. An expert advisory panel ensures relevance and accuracy of all findings.
Why This Report Matters
- Enables strategic planning by providing a detailed, actionable view of the Castleman Disease Treatment Market’s evolving landscape.
- Guides investment and partnership decisions with in-depth segmentation and regional analyses tailored for market entry and expansion strategies.
- Supports operational resilience by highlighting supply chain and regulatory trends that shape market risk and opportunity.
Conclusion
The Castleman Disease Treatment Market is shaped by rapid innovation, shifting operational dynamics, and a growing emphasis on personalized, patient-centered care. This report supports leaders in making informed, forward-looking decisions to drive sustainable growth and better clinical outcomes.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical trial advancements in investigational siltuximab biosimilars expanding treatment options for multicentric Castleman disease
5.2. Growing adoption of precision medicine approaches leveraging biomarkers to tailor Castleman disease therapy regimens
5.3. Rising investment in small molecule inhibitors targeting JAK-STAT signaling for refractory Castleman disease management
5.4. Increasing collaboration between academic centers and biopharma firms accelerating novel Castleman disease drug development
5.5. Regulatory approvals of next generation anti-IL-6 receptor agents transforming treatment landscape for Castleman patients
5.6. Enhanced patient access programs and reimbursement strategies improving affordability of rare disease therapies
5.2. Growing adoption of precision medicine approaches leveraging biomarkers to tailor Castleman disease therapy regimens
5.3. Rising investment in small molecule inhibitors targeting JAK-STAT signaling for refractory Castleman disease management
5.4. Increasing collaboration between academic centers and biopharma firms accelerating novel Castleman disease drug development
5.5. Regulatory approvals of next generation anti-IL-6 receptor agents transforming treatment landscape for Castleman patients
5.6. Enhanced patient access programs and reimbursement strategies improving affordability of rare disease therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Castleman Disease Treatment Market, by Treatment Type
8.1. Introduction
8.2. Chemotherapy
8.2.1. Combination Therapy
8.2.2. Monotherapy
8.3. Corticosteroids
8.3.1. Dexamethasone
8.3.2. Prednisone
8.4. Siltuximab
8.5. Tocilizumab
8.2. Chemotherapy
8.2.1. Combination Therapy
8.2.2. Monotherapy
8.3. Corticosteroids
8.3.1. Dexamethasone
8.3.2. Prednisone
8.4. Siltuximab
8.5. Tocilizumab
9. Castleman Disease Treatment Market, by Line Of Therapy
9.1. Introduction
9.2. First Line
9.2.1. Combination Therapy
9.2.2. Monotherapy
9.3. Later Lines
9.4. Second Line
9.2. First Line
9.2.1. Combination Therapy
9.2.2. Monotherapy
9.3. Later Lines
9.4. Second Line
10. Castleman Disease Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
10.2. Offline
10.3. Online
11. Castleman Disease Treatment Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.2.1. Self Administration
11.2.2. Visiting Nurse Services
11.3. Hospitals
11.4. Specialty Clinics
11.2. Home Care Settings
11.2.1. Self Administration
11.2.2. Visiting Nurse Services
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Castleman Disease Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Castleman Disease Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Castleman Disease Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Janssen Biotech, Inc.
15.3.2. Hoffmann-La Roche Ltd
15.3.3. Pfizer Inc.
15.3.4. EUSA Pharma (UK) Limited
15.3.5. Swedish Orphan Biovitrum AB
15.3.6. Grifols, S.A.
15.3.7. AbbVie Inc.
15.3.8. Takeda Pharmaceutical Company Limited
15.3.9. Novartis AG
15.3.10. Bristol-Myers Squibb Company
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Janssen Biotech, Inc.
15.3.2. Hoffmann-La Roche Ltd
15.3.3. Pfizer Inc.
15.3.4. EUSA Pharma (UK) Limited
15.3.5. Swedish Orphan Biovitrum AB
15.3.6. Grifols, S.A.
15.3.7. AbbVie Inc.
15.3.8. Takeda Pharmaceutical Company Limited
15.3.9. Novartis AG
15.3.10. Bristol-Myers Squibb Company
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CASTLEMAN DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CASTLEMAN DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CASTLEMAN DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CASTLEMAN DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CASTLEMAN DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. CASTLEMAN DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CASTLEMAN DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SILTUXIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SILTUXIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TOCILIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TOCILIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LATER LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LATER LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY VISITING NURSE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY VISITING NURSE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 104. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 105. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 106. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 107. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 108. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 109. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 110. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 116. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 199. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 215. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 218. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 219. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 222. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 223. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 247. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 250. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 251. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 252. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 253. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 254. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 255. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 256. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 257. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 262. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 263. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TA
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SILTUXIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SILTUXIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TOCILIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TOCILIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LATER LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LATER LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY VISITING NURSE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY VISITING NURSE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 104. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 105. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 106. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 107. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 108. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 109. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 110. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 116. CANADA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 199. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 215. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 218. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 219. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 222. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 223. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 247. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 250. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 251. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 252. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 253. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 254. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 255. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 256. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 257. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 262. ITALY CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 263. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY FIRST LINE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA CASTLEMAN DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TA
Samples
LOADING...
Companies Mentioned
- Janssen Biotech, Inc.
- Hoffmann-La Roche Ltd
- Pfizer Inc.
- EUSA Pharma (UK) Limited
- Swedish Orphan Biovitrum AB
- Grifols, S.A.
- AbbVie Inc.
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Bristol-Myers Squibb Company
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 380.66 Million |
| Forecasted Market Value ( USD | $ 720.87 Million |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
